Since the discovery of human iPS cells, a principal goal for researchers worldwide has been to use them for various medical ...

传统认为的糖尿病（主要指2型糖尿病）是中老年人的专利，儿童不会罹患，但事实上，在糖尿病的患病人群中，儿童并不少见。尤其是近年来随着儿童肥胖率明显上升，儿童2型糖尿病发病率呈快速增加趋势。儿童也会得糖尿病吗？会！我国糖尿病患者的发病率居世界首位，其中1 ...

Discover how vitamin D may hold the key to managing type 2 diabetes with new insights into its impact on insulin and glucose ...

In development GID-IND10278 Expected publication date: 27 November 2024 Register as a stakeholder ...

This narrative review summarises recently published epidemiological and in vivo experimental studies on exposure to environmental chemicals and their potential role in the development of type 1 ...

From 2010 to 2023, there was an increase in prescribing of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and s ...

Among different human diseases, type 1 diabetes mellitus (T1DM) has been a top priority for cell therapy development. While most basic research on human diseases utilizes rodents, such as mice and ...

仅供医学专业人士阅读参考每天学个热搜药。α-葡萄糖苷酶抑制剂（AGI）是一种临床常见的降糖药物，包括阿卡波糖、伏格列波糖和米格列醇。这3类药物之间有怎样的区别？除了常用的阿卡波糖，其他两种药物如何应用？AGI在指南中如何推荐？中国老年糖尿病诊疗指南（ ...

Can type 1 diabetes be managed or cured? Yes! Breakthrough treatments like Donislecel and Teplizumab offer hope for better ...